Intrinsic Value of S&P & Nasdaq Contact Us

Crescent Capital BDC, Inc. CCAP NASDAQ

NASDAQ Global Market • Financial Services • Asset Management • US • USD

SharesGrow Score
78/100
5/7 Pass
SharesGrow Intrinsic Value
$903.93
+6826.7%
Analyst Price Target
$14.00
+7.3%

Crescent Capital BDC, Inc. (CCAP) is a Asset Management company in the Financial Services sector, currently trading at $13.05. It has a SharesGrow Score of 78/100, indicating a strong investment profile with 5 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of CCAP = $903.93 (+6826.7% from the current price, the stock appears undervalued). Analyst consensus target is CCAP = $14 (+7.3% upside).

Valuation: CCAP trades at a trailing Price-to-Earnings (P/E) of 13.3 (S&P 500 average ~25).

Financials: revenue is $156M, +211.6%/yr average growth. Net income is $35M, growing at +124.7%/yr. Net profit margin is 22.1% (strong). Gross margin is 78% (+79.2 pp trend).

Balance sheet: total debt is $874M against $706M equity (Debt-to-Equity (D/E) ratio 1.24, moderate). Current ratio is 2.94 (strong liquidity). Debt-to-assets is 53.9%. Total assets: $1.6B.

Analyst outlook: 4 / 5 analysts rate CCAP as buy (80%) — strong consensus.

SharesGrow 7-Criteria breakdown: Value 71/100 (Pass), Growth 100/100 (Pass), Past 100/100 (Pass), Health 50/100 (Partial), Moat 58/100 (Partial), Future 82/100 (Pass), Income 85/100 (Pass).

$14.00
▲ 7.28% Upside
Average Price Target
The 12-month price target for Crescent Capital BDC, Inc. is $14.00.

CCAP SharesGrow Score Overview

78/100
SharesGrow Score
Strong investment profile
View full scorecard →
VALUE 71/100
Valuation — P/E, PEG, Forward PEG
GROWTH 100/100
Financials — average growth
PAST 100/100
strong — trend
HEALTH 50/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 58/100
Gross margin is + market cap
FUTURE 82/100
Analyst outlook — as buy
INCOME 85/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — CCAP

VALUE Pass
71/100
CCAP trades at a trailing Price-to-Earnings (P/E) of 13.3 (S&P 500 average ~25). Forward PEG -2.75 — Peter Lynch undervalued (≤1.0). Analyst consensus target is $14, implying +7.3% from the current price $13. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
GROWTH Pass
100/100
CCAP: +211.6%/yr revenue is, +124.7%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
PAST Pass
100/100
CCAP: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
~
HEALTH Partial
50/100
Balance sheet CCAP: Debt-to-Equity (D/E) ratio 1.24 (moderate), Current ratio is 2.94 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
58/100
CCAP: Gross margin is 78% (+79.2 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 58/100. ≥ 70 = Pass.
View details →
FUTURE Pass
82/100
Analyst outlook: 4 / 5 analysts rate CCAP as buy (80%). Analyst consensus target is $14 (+7.3% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
INCOME Pass
85/100
CCAP: Net profit margin is 22.1%. healthy (≥15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range11.8-17.02
Volume256.27K
Avg Volume (30D)212.36K
Market Cap$481.84M
Beta (1Y)0.60
Dividend Yield$1.7300
Share Statistics
EPS (TTM)0.93
Shares Outstanding$37.04M
IPO Date2020-02-03
CEOJason A. Breaux
Financial Highlights & Ratios
Revenue (TTM)$156.19M
Gross Profit$121.85M
EBITDA$103.11M
Net Income$34.51M
Operating Income$118.93M
Total Cash$31.5B
Total Debt$873.76M
Net Debt$-30.62B
Total Assets$1.62B
Price / Earnings (P/E)14
Price / Sales (P/S)3.09
Analyst Forecast
1Y Price Target$14.00
Target High$14.00
Target Low$14.00
Upside+7.3%
Rating ConsensusBuy
Analysts Covering5
Buy 80% Hold 20% Sell 0%
Price Target Summary
Company Info
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS2256551092

Price Chart

CCAP
Crescent Capital BDC, Inc.  ·  NASDAQ Global Market
Financial Services • Asset Management
11.80 52WK RANGE 17.02
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message